This is explained by PHF8 interaction with c-Jun and removal of H3K9me2 methylation to activate PRKCA (coding PKCα) and promote SRC-induced degradation of PTEN [23], a tumor suppressor commonly mutated in tumors and whose dysfunction is key to activate PI3K–AKT signaling. The gene discussed is PRKCA; the disease is neoplasm.